The U.S. Food and Drug Administration (FDA) recently granted orphan drug approval for Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia, which was developed by Jamaican scientist Dr. Henry Lowe.

Dr. Lowe founded Medicanja Ltd — described as “Jamaica's first medical cannabis company” — in 2013.

Its distinguished board of directors includes two former prime ministers and a former governor general.

Click here to read the complete article

GlobalVoices.org via 420Intel.com ~

Recent News Articles

Monday September 23

Arkansas: $1 million in pot taxes fill state coffers - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

The state of Arkansas surpassed the $1 million mark this week in taxes brought in…

137 hits

Monday September 23

Colorado marijuana companies are subject to federal labor laws despite being illegal, court rules -…

in Law & Crime

by Bruce Kennedy - Editor in Chief

A U.S. appeals court has ruled workers in Colorado’s marijuana industry are subject to overtime…

209 hits

Monday September 23

How Rock Climbers Can Use Marijuana In Recovery And Training - Cannabis News

in Sports

by Bruce Kennedy - Editor in Chief

Improved sleep, training motivation, and reduced anxiety are just some ways in which marijuana can…

128 hits

Monday September 23

More Illinois suburbs starting to say 'yes' to pot sales - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

The towns are part of an evolving scorecard of discussions taking place in the suburbs…

473 hits

Tuesday September 24

Uruguay makes first commercial marijuana export shipment - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

Uruguay has made its first commercial export shipment of marijuana since legalizing the drug in…

276 hits